Rising Costs of HIV Preexposure Prophylaxis May Hinder Benefit and Decrease Access
Researchers conducted a retrospective cohort study to analyze national trends in drug payments and other associated costs of HIV PrEP treatment.
News
Serious Infection Risk Not Significantly Higher With Denosumab vs Alendronate in Osteoporosis
Researchers assessed the serious infection risk for denosumab vs alendronate in real-world practice.
Hydrocortisone Did Not Reduce Mortality, Respiratory Support Need in COVID-19
Low-dose hydrocortisone was not associated with a significant reduction in death by day 21 of treatment compared with placebo in critically ill patients with COVID-19.
As Flu Season Approaches, Clinicians Brace for Potential ‘Twindemic’
Flu shots may be more important than ever this year, as COVID-19 presents new challenges for clinicians and communities this flu season.
Children, Adults With Tuberculosis Have Same Risk of Resistance in Most Countries
New study published in the European Respiratory Journal suggest that in most settings, the odds of drug resistance are the same for children and adults with TB, consistent with past research.
Hepatitis C-Negative Patients Receive Positive Kidney Transplants
A study published in the Annals of Internal Medicine found transplanting kidneys from hepatitis C virus (HCV)-positive donors to HCV-negative recipients (HCV D+/R-) may be successful with prophylactic treatment with direct-acting antivirals.
Maintaining Treat-to-Target Strategies for Rheumatoid Arthritis During the COVID-19 Pandemic
Treat-to-target and safe tapering strategies have been considered essential in the management of rheumatoid arthritis.
Racial/Ethnic Disparities in Access to Telehealth Visits: Results From the COVID-19 and Cancer Outcomes Study
Black and Hispanic patients were more likely to have COVID-19 but less likely to have an increase in telehealth visits.
Nosocomial Spread of COVID-19 Minimal With Rigorous Infection Control Measures
Findings from a study published in JAMA Network Open suggest that rigorous infection control measures may be associated with minimized risk and provide reassurance to patients concerned about contracting COVID-19 in hospitals.
Risk of Cardiac Events With Azithromycin, Amoxicillin Compared
The aim of the study was to use real-world data to compare the risk of cardiac events in new users of azithromycin vs amoxicillin.
COVID-19 Not Likely to Trigger Asthma Exacerbations in Hospitalized Patients
People with asthma were not overrepresented in patients with severe pneumonia because of SARS-CoV-2 infection who required hospitalization.
More Than Half of Pregnant Women With COVID-19 Asymptomatic
More than half of hospitalized pregnant women with COVID-19 are asymptomatic at admission, while pregnant women hospitalized for COVID-19-related illness have a higher prevalence of prepregnancy obesity and gestational diabetes.
Persistent High Rates of HBsAg Loss With IFN-α in Chronic HBV Suggestive of Its Potential
Researchers conducted a retrospective medical chart review to analyze relationship between HBsAg loss and a single PEG(IFN-α) course.
Warning Issued on Potentially Deadly Mosquito-Borne Virus in Michigan
Some Michigan residents are being told to stay indoors after dark and protect themselves from mosquito bites.
COVID-19 During Pregnancy May Pose Risks for Mother, Baby
Pregnant women with COVID-19 are less likely to report symptoms but are more likely to require intensive care unit admission compared with nonpregnant women of reproductive age.
A New Score to Identify High-Risk, Severe COVID-19 Patients
Researchers identified a prognostic BAS2IC score to assist physicians in identifying patients at high-risk of developing early severe COVID-19.
Rates of New HPV Detection and Loss of Detection in Middle-Age Women
Researchers conducted a prospective cohort study to assess rates of new HPV detection and loss of detection in middle-age women.
Flu Activity Low in Southern Hemisphere in June to August
There was very low influenza activity during June to August 2020 in the Southern Hemisphere.
Vaccine Campaign Would Take Six to Nine Months to Curb COVID-19
Once a vaccine becomes available, the first to be vaccinated would be those with health conditions that make them most vulnerable.
Cost-Effectiveness of Universal and Targeted Hepatitis C Screening
Researchers conducted a simulated economic evaluation cohort analyses to assess the cost-effectiveness of HCV screening and compared other screening programs in the United States.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in News
